CB2 Receptor Activation: Immune Modulation, Inflammation Relief, and More!
It’s not just about the “high,” after all.
It’s been over three years since cannabis legalization in Canada. Interest continues to grow around its use as medicine and how it can play a positive role in one’s natural health lifestyle.
However, many who would love to take advantage of its health benefits often look for alternatives to avoid the “high” sought out by recreational users.
The great news is that there are many other compounds in cannabis that can bring about those same health benefits without intoxication.
While much of the focus has been on cannabinoids (CBD, CBG, CBN etc.), another class of compounds called terpenes is gaining attention. Numerous publications consider it equally important, if not more important, than the cannabinoids.
And this all centres around how they interact with the endocannabinoid system (ECS).
The Endocannabinoid System
The ECS is often called the master regulator of homeostasis — balance within the body — and is found within every tissue and organ. It’s made up of two primary cannabinoid receptors (called CB1 and CB2) and “endocannabinoids” that are produced by the body and mimic the “phytocannabinoids” from cannabis.
When the normal function of our tissues or organs is disrupted, that specific area of the body produces more cannabinoid receptors. They do this so that they can be activated by the endo- or phytocannabinoids to bring things back into balance.
In particular, CB2 receptors are an exciting therapeutic target that recent studies (and drug development companies) are focused on. Since they’re primarily located outside the central nervous system, their activation does not result in intoxication.
CB2 Receptors and Immune System Modulation
The immune system contains the most significant amount of CB2 receptors in the body.
So, what happens when the CB2 receptors are activated?
Activating CB2 receptors can moderate the immune system, benefiting autoimmune conditions. It also helps tame an overly aggressive immune response that results in tissue damage and worsening symptoms.
Cannanda CB2™ Terpenes
Many consider terpenes more important than classical cannabinoids.
While cannabis terpenes have invigorated scientific interest in their health benefits, terpenes are naturally found in abundance throughout the plant kingdom — not just cannabis.
Cannanda, a multi-award-winning brand, now makes it easy for patients and consumers to leverage the power of terpenes in a manner that’s entirely legal for sale in any clinic or health food store. These physician-formulated blends are highly targeted to specific biological processes, according to the author.
For CB2 receptor activation, Cannanda has developed the first of its kind, the award-winning CB2™ line. The products effectively target your ECS and activate CB2 receptors in a manner similar to THC and CBD, but without the high.
This Canadian brand is also sold in the UK, Australia, and South Korea, with thousands of incredible life-changing testimonials worldwide.
For Pain, Anxiety and So Much More
- Heart disease and cardiovascular health
- Insulin sensitivity, obesity, and other metabolic conditions
- Dementia, Alzheimer’s, Parkinson’s disease, and other neurodegenerative conditions
- Multiple sclerosis, rheumatoid arthritis, and other autoimmune conditions
- Osteoarthritis and joint pain
- Migraines and headaches
- Insomnia… and the list goes on.
Small Investment for Fast Results
While many products on the market can take months to work and cost a considerable amount during that time, Cannanda CB2™ products often work within the first week or two. Many users report it works from the very first dose, almost instantly!
Along with a hassle-free money-back guarantee in the event they don’t work for your unique physiology, you’ve got nothing to lose and everything to gain.
So, give these award-winning products a try — your health and wallet will thank you.
Lee Know is a licensed naturopathic doctor, recipient of several awards, and has held positions as medical advisor, scientific evaluator and director of R&D for major organizations. He’s the author of Mitochondria and the Future of Medicine (Chelsea Green Publishing, 2018) and leads Scientific Affairs for Cannanda.